← Browse by Condition
Medical Condition

second line

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05927857 Phase 1, Phase 2
Recruiting

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Enrollment
45 pts
Location
Taiwan
Sponsor
National Health Research Insti...
View Trial →